share_log
Reuters ·  Jan 10 13:05
NextCure Announces First Patient Dosed in the Phase 1 Study of Lncb74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 371

Recommended

Write a comment